Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 190-197

  Godsland, I F ^a,c   Crook, D ^a,b   Proudler, A J ^a   Stevenson, J C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOSTASIS; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID STORAGE; LIVER FUNCTION; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL, LDL; FACTOR X; FIBRINOGEN; GAMMA-GLUTAMYLTRANSFERASE; HEMOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 12244256099     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1292     Document Type: Article

References (43)

1. Reaven G 1988 Banting Lecture: role of insulin resistance in human disease. Diabetes 37:1595-1607
2. Björntorp P 1991 Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143
3. Modan M, Halkin H, Karasik A, Lusky A 1987 Elevated serum uric acid: a facet of hyperinsulinaemia. Diabetologia 30:713-718
4. Jeppesen J, Hollenbeck CB, Zhou MY, Coulston AM, Jones C, Chen YD, Reaven G 1995 Relation between insulin resistance, hyperinsulinaemia, post-heparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 15:320-324
5. Haffner SM, Stem MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK 1990 Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects. Arteriosclerosis 10:727-731
6. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610
7. Festa A, D'Agostino RJ, Howard G, Mykkanen L, Tracy RP, Haffner SM 2000 Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47
8. Juhan-Vague I, Thompson SG, Jespersen J 1993 Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13:1865-1873
9. Alberti KGM, Zimmet PZ; for the WHO Consultation 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Provisional Report of a WHO Consultation. Diabet Med 15:539-553
10. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2001 Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285:2486-2497
11. Agewall S, Bokemark L, Wikstrand J, Lindahl A, Fagerberg B 2000 Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men. Thromb Haemost 84:571-575
12. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP 2000 Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152:897-907
13. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J 2002 Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25:1371-1377
14. Godsland IF, Leyva F, Worthington M, Walton C, Stevenson JC 1998 Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). J Intern Med 244:33-41
15. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG 2001 Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86:719-723
16. Walton C, Lees B, Crook D, Worthington M, Godsland IF, Stevenson JC 1995 Body fat distribution rather than overall adiposity influences serum lipids and lipoproteins in healthy men independently of age. Am J Med 99:459-464
17. Ley C, Lees B, Stevenson J 1992 Sex- and menopause-associated changes in body fat distribution. Am J Clin Nutr 55:950-954
18. Bergman RN, Ider YZ, Bowden CR, Cobelli C 1979 Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677
19. Walton C, Godsland IF, Proudler AJ, Felton C, Wynn V 1992 Evaluation of four mathematical models of glucose and insulin dynamics with analysis of the effects of age and obesity. Am J Physiol 262:E755-E762
20. Swan J, Walton C, Godsland IF 1994 Assessment of insulin sensitivity in man: a comparison of minimal model and euglycaemic clamp derived measures in health and heart failure. Clin Sci (Lond) 86:317-322
21. Toffolo G, Bergman R, Finegood D, Bowden C, Cobelli C 1980 Quantitative estimation of β cell sensitivity to glucose in the intact organism. Diabetes 29:979-990
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
23. Leyva F, Godsland IF, Walton C, Worthington M, Stevenson JC 1998 Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vasc Biol 18:208-214
24. Asplund-Carlson A, Hamsten A, Wiman B, Carlson LA 1993 Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 36:817-825
25. Freeman MS, Mansfield MW, Barrett JH, Grant PJ 2003 Insulin resistance: an atherothrombotic syndrome. The Leeds family study. Thromb Haemost 89: 161-168
26. Kain K, Catto AJ, Grant PJ 2003 Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects. Diabet Med 20: 651-655
27. Romano M, Guagnano MT, Pacini G, Vigneri S, Falco A, Marinopiccoli M, Manigrasso MR, Basili S, Davi G 2003 Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab 88:5321-5326
28. Perry IJ, Wannamethee SG, Shaper AG 1998 Prospective study of γ-glutamytransferase and risk of NIDDM. Diabetes Care 21:232-237
29. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA 2000 γ-Glutamyl transpeptidase and the metabolic syndrome. J Intern Med 248:230-238
30. Yokoyama H, Moriya S, Homma Y, Ogawa T 2003 Association between γ-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome. Alcohol Clin Exp Res 27(8 Suppl):22S-25S
31. Moriya S, Yokoyama H, Hirose H, Ishii H, Saito I 2003 Correlation between insulin resistance and γ-glutamyl transpeptidase sensitivity in light drinkers. Alcohol Clin Exp Res 27(8 Suppl):52S-57S
32. Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, Ohba K, Isomoto H, Mizuta Y, Hayashida K, Murase K, Kadota T, Murata I, Kohno S 2002 Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 17:1098-1105
33. 1993 ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary atherosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 14:8-17
34. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK 1993 Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:762-767
35. Green D, Ruth KJ, Folsom AR, Liu K 1994 Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterisoscler Thromb 14:686-693
36. Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L 1996 Population correlates of coagulation factor VII. Importance of age, sex and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol 16:1170-1176
37. Ohni M, Mishima K, Nakajima K, Yamamoto M, Hata Y 1995 Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1. J Atheroscler Thromb 2(Suppl 1):S41-S46
38. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A 1994 Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 14:60-69
39. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK 1994 Associations of factor VII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 71:528-529
40. Feskens EJ, Kromhout D 1994 Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study. Arterisoscler Thromb 14:1641-1647
41. Avellone G, Di Garbo V, Cordova R, Raneli G, De Simone R, Bompiani G 1994 Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 75:223-231
42. Licata G, Scaglione R, Avellone G, Ganguzza A, Corrao S, Arnone S, Di Chiara T 1995 Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Metabolism 44:1417-1421
43. Mertens I, Van Gaal LF 2002 Obesity, haemostasis and the fibrinolytic system. Obes Rev 3:85-101